Behind Canada’s current COVID-19 vaccine shortage is a decades-long tale of unheeded warnings, missed opportunities and dismantled resources that was never going to end well.
Freelancers who have lost work during the COVID-19 crisis can take steps to ensure they have a successful long-term career in the post-pandemic period.
Advertisers forked over $5.5 million for a mere 30 seconds of air time during the Super Bowl. Here’s Twitter’s verdict on which brands got social media bang for their bucks.
Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from the vaccines.
Food production in the US is heavily concentrated in the hands of a small number of large agribusiness companies. That’s been good for shareholders, but not for consumers.
Yes, this news is disappointing - but it’s also no great surprise given how quickly this virus mutates. And it doesn’t yet mean Australia should bin its plan to use the AstraZeneca vaccine.
The decision to go south for the winter during the ongoing pandemic is a complex one, informed by factors such as availability of recreational opportunities and cost of living.
Like other innovations borne out of challenging times in history, the push for more automation and tele-operation triggered by the COVID-19 pandemic must mean more efficient and safer workplaces.
Giving money to support local production of COVID-19 vaccines is a step in the right direction if it will help in resuscitating Nigeria’s vaccine production laboratory.
Employers like Pimlico Plumbers may want to get authoritarian about vaccinating those who work for them, but they’ll have a hard time justifying it in court.
Vaccine developers pledge to create boosters that can better handle the new variants of the virus, and new data gives reassurance on the Oxford vaccine.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand